Related Experiment Video
Updated: Aug 16, 2026

Probiotic Studies in Neonatal Mice Using Gavage
Published on: January 27, 2019
Routine probiotics and outcomes in infants < 29 weeks: a 13-year single-centre cohort with propensity-weighted
ThankGod Omereji1, Sarah Wigston1, Yordanka Karayaneva2
1Neonatal Unit, James Cook University Hospital, Marton Road, Middlesbrough, TS4 3BW, UK.
Insights
Routine probiotic use in extremely preterm infants was associated with significantly lower in-hospital mortality. While benefits for necrotizing enterocolitis (NEC) and late-onset sepsis were not clear, this study highlights mortality reduction in vulnerable infants.
Area of Science:
- Neonatal intensive care
- Pediatric gastroenterology
- Clinical pharmacology
Background:
- Probiotic supplementation in preterm infants shows variable effects on necrotizing enterocolitis (NEC) and mortality.
- Existing research lacks representation of extremely preterm infants and has heterogeneity in probiotic products and co-interventions.
Purpose of the Study:
- To evaluate the association between probiotic supplementation and outcomes in infants born at <29 weeks' gestation.
- To assess the impact of probiotics on in-hospital mortality, severe NEC, and late-onset sepsis (LOS).
Main Methods:
- Retrospective cohort study of 581 infants born <29 weeks' gestation (2012-2024).
- Compared outcomes between infants receiving probiotics (n=502) and those not receiving probiotics (n=79).
- Used multivariable logistic regression and propensity-score weighting for analysis, adjusting for key covariates.
Main Results:
- Probiotic exposure was associated with significantly lower in-hospital mortality (aOR 0.31; p=0.036).
- In-hospital mortality was 4.8% in probiotic-exposed infants versus 13.9% in unexposed infants.
- No clear association was found between probiotic use and severe NEC or culture-positive LOS.
Conclusions:
- Routine probiotic use in extremely preterm infants (<29 weeks' gestation) is linked to reduced in-hospital mortality.
- The study did not demonstrate clear benefits of probiotics for severe NEC or LOS in this population.
- Findings suggest a potential mortality benefit, warranting further investigation in diverse preterm infant cohorts.
Abstract:
Probiotic supplementation in preterm infants has been associated with reduced necrotising enterocolitis (NEC) and mortality, but reported effects vary across studies due to heterogeneity in populations, probiotic products, and co-interventions, with limited representation of extremely preterm infants. We performed a single-centre retrospective cohort study of infants born at < 29 weeks' gestation admitted for intensive care between 2012 and 2024 using electronic patient records. After excluding infants who died within the first 7 days and other predefined exclusions, 581 infants were analysed: 79 (13.6%) received no probiotics and 502 (86.4%) received probiotics (two products used sequentially during the study period). Baseline characteristics (gestational age, birthweight, sex, and antenatal steroid exposure) were similar between groups. Primary outcomes were in-hospital mortality and severe NEC, defined pragmatically as NEC requiring transfer for surgical management and/or surgery. Secondary outcomes included culture-positive late-onset sepsis (LOS) and time to full enteral feeds. Associations were examined using multivariable logistic regression adjusting for gestational age, birthweight, sex, antenatal steroid exposure, and calendar year, supported by propensity-score overlap-weighted sensitivity analysis. In-hospital mortality was 4.8% in probiotic-exposed infants versus 13.9% in unexposed infants. Probiotic exposure was associated with lower adjusted odds of in-hospital mortality (aOR 0.31; 95% CI 0.10-0.93; p = 0.036). No clear association was observed with severe NEC or culture-positive LOS.
Conclusion:
In this 13-year single-centre cohort of infants < 29 weeks' gestation, routine probiotic use was associated with lower in-hospital mortality, while effects on severe NEC and LOS were not clearly demonstrated.
What Is Known:
• Probiotic supplementation in preterm infants has been associated with reduced NEC and mortality, but results vary across studies. • Prior evidence is heterogeneous, with limited representation of extremely preterm infants and variability in probiotic strains, dosing, and co-interventions.
What Is New:
• In a 13-year single-centre cohort of infants < 29 weeks' gestation, probiotic use was associated with lower in-hospital mortality after adjustment. • No clear difference in severe NEC (surgery/transfer) was observed between probiotic-exposed and unexposed infants.
Related Concept Videos
Development of Human Microbiota
Microbiota Modulation by Antibiotics
Development of the Oral Microbiota
